Pharmafile Logo

Event Logistics

- PMLiVE

Merck cuts MK-3475 deals with Pfizer, Amgen and Incyte

Sees combination potential for cancer prospect

- PMLiVE

GSK starts recovery from China crisis as growth returns

Sales increase after two years of declines

- PMLiVE

FDA deems GSK anaemia drug a ‘breakthrough’

US regulator will accelerate review of Promacta

XenoPort appoints chief medical officer

Richard Kim led Tysabri programme at Biogen Idec

- PMLiVE

Debunking cancer myths

World Cancer Day seeks to challenge preconceptions

- PMLiVE

inVentiv announces Appinions alliance

Will develop 'healthcare influence index'

- PMLiVE

Three new faces at GCI Health

Healthcare communications agency is developing its London team

- PMLiVE

Interview: Julia Kendrick

Allergan's in-house PR counsel on winning Communiqué 2013's Young Achiever

- PMLiVE

Pfizer partners with Siemens on diagnostics

Will develop companion diagnostics to support clinical studies

- PMLiVE

NIH forges $230m research alliance with pharma

Brings 10 pharma companies together to speed up research in Alzheimer’s, diabetes and arthritis

Biogen Idec building

EC approves Biogen’s oral MS drug Tecfidera

Will compete with Novartis' Gilenya and Sanofi's Aubagio

Aesica creates commercial MD role

Appoints Catalent’s Ian Muir to new position

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links